Turkey Astrovirus

Overview and Taxonomy of Turkey Astrovirus

Historical Context and Discovery

The recognition of turkey astrovirus (TAstV) as a distinct etiological agent of enteric disease in commercial poultry traces back to the late 20th century, when the first small round virus particles (18–24 nm) were identified in the gut contents of turkey poults suffering from an outbreak of enteritis [23]. This initial detection, occurring in a natural outbreak where Salmonella, group D rotavirus, and astrovirus were concurrently present, marked the beginning of a decades-long effort to disentangle the complex viral ecology of turkey enteric syndromes. The virus was subsequently isolated and characterized from poults affected by poult enteritis mortality syndrome (PEMS), a devastating condition that causes substantial economic losses in turkey flocks worldwide [20]. Early diagnostic methods relied heavily on electron microscopy and fluorescent antibody testing, but the advent of molecular tools, particularly reverse transcription polymerase chain reaction (RT-PCR) targeting the capsid and polymerase genes, revolutionized the detection and characterization of TAstV [20]. These molecular advances revealed that TAstV is not a single, monotypic agent but rather a genetically diverse group of viruses that are now recognized as major contributors to poult enteritis complex (PEC) and poult enteritis syndrome (PES) across all major turkey-producing regions, including North America, Europe, South America, and Asia [2-4, 7, 13, 16, 17, 19, 22].

Taxonomic Classification within the Astroviridae Family

Turkey astrovirus belongs to the family Astroviridae, which is divided into two genera: Mamastrovirus (infecting mammals) and Avastrovirus (infecting birds) [14, 15]. The Avastrovirus genus encompasses viruses that infect a broad range of avian hosts, including chickens, turkeys, ducks, geese, pheasants, and even wild passerine birds such as the black-naped monarch (Hypothymis azurea) [6, 10, 15, 24]. Within the avastroviruses, turkey astroviruses are classified into two distinct types, TAstV-1 and TAstV-2, and a related virus, avian nephritis virus (ANV), which is also frequently detected in turkeys and is often grouped with the avastroviruses [8, 14, 25]. The type differentiation is based on antigenic, genetic, and pathogenic criteria. TAstV-2 is the more prevalent and better-characterized type, having been associated with the majority of enteric disease outbreaks in turkeys [2, 3, 13, 19, 21, 26]. TAstV-1, while also detected, has been reported in lower prevalence and is often found in co-infections with TAstV-2 and other enteric viruses [8, 17, 19]. ANV, originally described in chickens and associated with nephritis and runting-stunting syndrome, has been identified in turkey flocks and is now classified within Avastrovirus genogroup 2, sharing partial genomic homology with turkey astroviruses [10, 25, 27].

At the genomic level, TAstV is a small, non-enveloped, positive-sense single-stranded RNA virus with a genome length of approximately 6.8 to 7.2 kb [14, 20, 21]. The genome encodes three open reading frames (ORFs): ORF1a and ORF1b, which encode non-structural proteins including the RNA-dependent RNA polymerase (RdRp) and a serine protease, and ORF2, which encodes the capsid protein (the major structural protein responsible for antigenicity and host interactions) [12, 18, 21, 24]. The ORF1b/RdRp gene is relatively conserved among astroviruses and is frequently used for phylogenetic analysis and molecular detection, whereas the ORF2/capsid gene is highly variable, with nucleotide sequence identities among TAstV-2 isolates as low as 69% [21]. This marked genetic variability in the capsid gene underpins the antigenic diversity of TAstV and has important implications for diagnostics, vaccine development, and the potential for immune evasion.

Genetic Diversity and Phylogenetic Relationships

Phylogenetic analyses of TAstV isolates from diverse geographic regions have consistently demonstrated substantial genetic heterogeneity, particularly in the capsid region [21, 26]. In one seminal study of 23 TAstV isolates collected from commercial turkey flocks across the United States between 2003 and 2004, researchers reported that isolates obtained from different houses on the same farm on the same day could share as little as 72% nucleotide identity in their capsid genes [21]. This degree of diversity far exceeds that seen in many other RNA viruses and suggests that TAstV undergoes rapid evolution, likely driven by both point mutations and recombination events. Indeed, phylogenetic incongruence between the capsid and polymerase gene trees has provided compelling evidence for recombination in TAstV, a phenomenon that contributes to the emergence of novel variants and may facilitate host range expansion [14, 21]. Recombination has also been documented between TAstV and other avastroviruses, including goose astrovirus (GAstV), where a recombination event occurred between GAstV strain TZ03 and turkey astrovirus CA/00 in the 3′ region of the genome [5, 9, 24]. Such inter-species recombination events underscore the fluid genetic boundaries within the Avastrovirus genus and highlight the potential for the emergence of novel viruses with altered pathogenic or zoonotic properties.

Global surveillance efforts have revealed distinct genetic lineages of TAstV-2. North American isolates have formed clusters that are often geographically distinct from European isolates. For instance, Polish TAstV-2 strains detected in a 2008 molecular survey grouped into a distinct “European” subgroup, separate from the North American prototype strains, indicating separate evolutionary trajectories [19]. Similarly, sequences from Ecuador were shown to cluster closely with those from Brazil and other South American countries, suggesting possible routes of introduction via the international trade of poultry or migratory birds [8]. The detection of TAstV in wild birds, such as ruddy turnstones (Arenaria interpres) in Brazil, which yielded a nearly complete genome of a novel astrovirus (Ruddy turnstone astrovirus, RtAstV) that formed a monophyletic clade with poultry astroviruses, raises the possibility that wild avian reservoirs serve as a source of genetic diversity and may play a role in the introduction of astroviruses into commercial flocks [11].

The taxonomy of turkey astrovirus is further complicated by the presence of ANV and its relationship to TAstV. ANV is classified within Avastrovirus genogroup 2 and shares significant sequence homology with TAstV-2 in the RdRp gene, but diverges in the capsid gene [25]. In surveys of turkey flocks, ANV has been detected both in pure infections and in co-infections with TAstV-1 and TAstV-2 [8, 17, 19]. The International Committee on Taxonomy of Viruses (ICTV) currently recognizes several species within the Avastrovirus genus, including Avastrovirus 1 (which primarily includes chicken and turkey astroviruses), Avastrovirus 2 (avian nephritis viruses), and Avastrovirus 3 (duck and goose astroviruses). However, the rapid accumulation of sequence data from diverse avian hosts is challenging this static classification, as evidenced by the discovery of astroviruses in pheasants with sequences sharing ORF-1b identity with TAstV-1 [6], and the detection of chicken astrovirus (CAstV) as the predominant cause of hatchery condemnations in commercial turkeys in southwestern Nigeria [10]. In the latter study, 83.5% of condemned or runted day-old turkey poults tested positive for CAstV (belonging to the Bi clade), while TAstV was not detected, indicating that cross-species infection with astroviruses from other avian hosts is not only possible but may be economically significant in certain production systems [10]. Conversely, experimental studies have shown that TAstV-2 can induce serological responses in humans with occupational exposure to turkeys, raising questions about the potential for zoonotic transmission, although no clinical disease has been documented [1].

Implications for Epidemiology and Pathogenesis

The taxonomic classification of TAstV is not merely a matter of nomenclature; it has direct consequences for understanding the epidemiology and pathogenesis of enteric diseases in turkeys. TAstV-2 has been consistently associated with clinical disease in young poults, including diarrhea, depression, stunting, and reduced weight gain, whereas TAstV-1 is often detected in subclinical infections or as part of mixed infections [2, 17, 26]. Experimental inoculation studies have demonstrated that TAstV-2 isolates derived from flocks with PES are more pathogenic than those from apparently healthy flocks, suggesting the existence of pathotypes with differing virulence [2]. The virus induces disease without significant inflammation or histological damage to the intestinal epithelium; instead, it disrupts epithelial barrier function by redistributing the sodium-hydrogen exchanger 3 (NHE3) from the cell membrane to the cytoplasm, leading to sodium malabsorption and osmotic diarrhea [12, 18]. Remarkably, oral administration of the purified recombinant TAstV-2 capsid protein alone is sufficient to induce acute diarrhea in poults, indicating that the capsid protein acts as an enterotoxin that reproduces the natural route of infection [12]. This pathomechanism is reminiscent of rotavirus NSP4 enterotoxin activity and underscores the unique pathogenic strategy of astroviruses among enteric viruses.

From a taxonomic perspective, understanding which genetic elements determine virulence, whether they reside in the capsid gene or in non-structural protein regions, remains an active area of research. The high capsid variability and the presence of recombination events complicate efforts to develop broadly protective vaccines. For example, phylogenetic analysis of TAstV-2 isolates from Minnesota revealed clustering into two distinct groups based on RdRp sequences, and these groups may correspond to differences in pathogenicity [26]. The World Organisation for Animal Health (WOAH) recognizes astrovirus as a significant pathogen in poultry, and the Food and Agriculture Organization (FAO) has highlighted the need for improved surveillance of enteric viruses in poultry production systems to mitigate economic losses and safeguard food security. The Centers for Disease Control and Prevention (CDC) has also noted the potential for astrovirus zoonotic transmission given the detection of antibodies in abattoir workers [1], emphasizing that the taxonomic boundaries between mammalian and avian astroviruses may be more permeable than previously assumed. As next-generation sequencing and metagenomic approaches continue to uncover novel astroviruses in both domestic and wild birds, the taxonomy of turkey astrovirus will undoubtedly require ongoing revision. The current framework, which organizes TAstV-1, TAstV-2, and ANV within the Avastrovirus genus, provides a solid foundation, but the detection of recombinant and inter-species strains is a clear signal that the evolutionary dynamics of these viruses are far from static [9, 14, 21, 24].

Molecular Pathogenesis of Turkey Astrovirus

The molecular pathogenesis of turkey astrovirus (TAstV) represents a paradigm-shifting narrative in enteric virology, challenging long-held dogmas about how non-enveloped RNA viruses induce diarrheal disease. Unlike classical enteric pathogens that rely on epithelial destruction, inflammation, or cytolytic replication, TAstV orchestrates a sophisticated, non-cytolytic mechanism of disease that is mediated primarily by its structural capsid protein. This section provides an exhaustive, mechanistic dissection of the molecular events underlying TAstV infection, from viral entry and genomic replication to the disruption of intestinal ion transport and barrier function, with particular emphasis on the enterotoxic properties of the capsid and the implications for interspecies transmission.

The Enterotoxic Capsid: A Non-Inflammatory Diarrheal Mechanism

The most striking and pathognomonic feature of TAstV pathogenesis is the discovery that the viral capsid protein alone is sufficient to induce acute diarrhea in the absence of viral replication. This finding, established through a landmark study using the turkey poult model, fundamentally redefines our understanding of astrovirus disease [12]. Oral administration of purified recombinant TAstV-2 capsid protein to turkey poults produced dose- and time-dependent diarrhea that was clinically indistinguishable from that induced by live, replication-competent virus. Critically, this capsid-induced diarrhea occurred without any detectable histological damage, inflammation, or cellular infiltration, a hallmark that distinguishes astrovirus infection from rotavirus, coronavirus, or bacterial enteritides [12, 18]. This observation aligns with earlier in vitro studies using human astrovirus serotype 1 (HAstV-1), which demonstrated that the capsid spike protein alone disrupts the actin cytoskeleton and tight junction complexes in differentiated Caco-2 intestinal epithelial cells, leading to increased paracellular permeability [12].

The molecular basis for this enterotoxic activity lies in the capsid protein’s ability to act as a viral enterotoxin, a property previously thought to be exclusive to rotavirus non-structural protein NSP4. The TAstV-2 capsid, upon binding to intestinal epithelial cells, triggers a signaling cascade that results in the redistribution of the sodium-hydrogen exchanger isoform 3 (NHE3) from the apical membrane to the cytoplasmic compartment [12, 18]. NHE3 is the primary transporter responsible for electroneutral sodium absorption in the small intestine, and its functional loss leads to sodium malabsorption, which in turn creates an osmotic gradient that drives water into the intestinal lumen, producing diarrhea. Electrophysiological studies using Ussing chambers have confirmed that TAstV-2 infection significantly reduces net sodium absorption across the intestinal epithelium, while leaving chloride secretion largely unaffected [18]. This selective inhibition of sodium transport, coupled with the observed rearrangement of filamentous actin (F-actin) in the terminal web region of enterocytes, provides a unified molecular mechanism for the watery, non-inflammatory diarrhea characteristic of astrovirus infection [18].

Ultrastructural Remodeling and Barrier Dysfunction

Beyond ion transporter redistribution, TAstV infection induces profound ultrastructural changes in the intestinal epithelium that contribute to barrier dysfunction. Transmission electron microscopy of infected poult intestines reveals a reorganization of the actin cytoskeleton, particularly within the microvillar core and the perijunctional actomyosin ring [18]. This cytoskeletal remodeling is not accompanied by cell death or sloughing of enterocytes, distinguishing it from the pathology seen in rotavirus or coronavirus infections. Instead, the integrity of the epithelial monolayer is maintained, but its functional permeability is increased. The capsid protein appears to interact directly with host cell surface receptors, possibly integrins or tight junction-associated proteins, to activate Rho GTPase signaling pathways that modulate actin dynamics [12]. The result is a "leaky" epithelium that permits paracellular flux of small molecules and ions, further exacerbating the osmotic diarrhea initiated by NHE3 internalization.

Importantly, the capsid-induced barrier dysfunction is independent of viral replication, as demonstrated by the efficacy of UV-inactivated virus and purified recombinant capsid in inducing these changes [12]. This has profound implications for understanding the natural history of TAstV infection: even in the absence of robust viral replication, ingestion of capsid protein from degraded virions in contaminated feed or water could theoretically contribute to disease. This mechanism may explain the rapid onset of diarrhea in young poults following exposure to TAstV-contaminated environments, as viral capsid protein can act immediately upon contact with the intestinal epithelium without requiring a full replication cycle.

Host Innate Immune Responses: The Role of Inducible Nitric Oxide Synthase

While TAstV infection is notably non-inflammatory, it does elicit a specific innate immune response that may paradoxically contribute to pathogenesis. The inducible nitric oxide synthase (iNOS) enzyme, a key mediator of antimicrobial innate immunity, is upregulated in intestinal epithelial cells following TAstV infection [28]. Using the turkey poult model, researchers have demonstrated that iNOS mRNA and protein expression are significantly increased in the intestinal epithelium of infected birds, and that this expression is localized to the enterocytes themselves rather than infiltrating immune cells [28]. The induction of iNOS leads to the production of nitric oxide (NO), a reactive nitrogen species with potent antiviral and immunomodulatory properties.

However, the role of NO in TAstV pathogenesis is likely dual-edged. While NO can inhibit viral replication through nitrosylation of viral proteins and disruption of viral RNA synthesis, excessive NO production can also damage host cell mitochondria, inhibit ion transporter function, and contribute to the metabolic dysregulation that underlies the growth retardation observed in infected poults [2, 28]. The induction of iNOS by TAstV capsid protein, independent of viral replication, suggests that the host innate immune system recognizes the capsid as a pathogen-associated molecular pattern (PAMP), possibly through Toll-like receptors or other pattern recognition receptors on the epithelial surface. This response, while intended to control infection, may inadvertently amplify the diarrheal disease by further disrupting epithelial ion transport and barrier function through NO-mediated S-nitrosylation of NHE3 and tight junction proteins.

Genetic Determinants of Pathogenicity: Strain Variation and Recombination

Not all TAstV strains are created equal. Experimental inoculation studies have demonstrated that TAstV-2 isolates derived from flocks suffering from poult enteritis syndrome (PES) are significantly more pathogenic than isolates obtained from apparently healthy flocks [2]. Birds infected with PES-derived TAstV-2 exhibited more severe diarrhea, greater weight suppression, and a significant reduction in bursa of Fabricius size compared to birds infected with non-pathogenic field strains [2]. This differential pathogenicity suggests that specific genetic determinants within the TAstV genome govern virulence.

Phylogenetic analyses of TAstV isolates from diverse geographic regions have revealed a high degree of genetic variability, particularly in the capsid (ORF2) gene, where nucleotide sequence identity among isolates can be as low as 69% [21]. This hypervariability is concentrated in the surface-exposed domains of the capsid spike protein, which are likely under selective pressure from host antibodies and may also determine receptor binding specificity and enterotoxic activity. Importantly, phylogenetic incongruence between the capsid and polymerase (ORF1b) genes has provided compelling evidence for recombination in TAstV evolution [21]. Isolates collected from the same farm on the same day but from different houses can have capsid sequences that differ by as much as 28%, while their polymerase genes remain highly conserved [21]. This pattern is consistent with frequent recombination events, likely occurring during co-infection of the same host with multiple TAstV strains.

Recombination has been documented not only within TAstV but also between TAstV and other avian astroviruses. For instance, a recombination event between goose astrovirus (GAstV) strain TZ03 and turkey astrovirus CA/00 was detected in the 3' region of the genome (nucleotides 6833-7070) of novel GAstV isolates from China [5]. Such interspecies recombination events highlight the potential for TAstV to serve as a genetic donor or recipient in the emergence of novel astroviruses with altered host range or pathogenicity. The capsid gene, in particular, appears to be a hotspot for recombination, and the exchange of capsid domains between different TAstV genotypes could generate viruses with enhanced enterotoxic activity, altered tissue tropism, or the ability to evade pre-existing immunity in vaccinated flocks.

Tissue Tropism and Systemic Dissemination

While TAstV is primarily considered an enteric pathogen, molecular evidence indicates that the virus can disseminate beyond the gastrointestinal tract, with significant implications for pathogenesis. RT-PCR and immunohistochemical studies have detected TAstV RNA and antigen in the bursa of Fabricius, thymus, and spleen of infected poults, particularly in cases of poult enteritis complex (PEC) [3]. The presence of viral RNA in lymphoid tissues suggests that TAstV may have a tropism for immune cells, potentially contributing to the immunosuppression observed in severely affected flocks. Histological examination of these tissues reveals atrophy, lymphoid depletion, cellular infiltration, and necrosis, indicating that TAstV infection can directly damage primary and secondary lymphoid organs [3].

The mechanism of systemic dissemination is not fully understood, but it is hypothesized that TAstV may cross the intestinal epithelial barrier via M cells or through the paracellular route following capsid-induced tight junction disruption. Once in the lamina propria, the virus could infect resident macrophages or dendritic cells, which then transport it to draining lymph nodes and subsequently to systemic lymphoid tissues. The detection of TAstV in the bursa of Fabricius is particularly noteworthy, as this organ is critical for B-cell development and antibody production in birds. Bursal atrophy induced by TAstV infection could impair the humoral immune response, rendering poults more susceptible to secondary infections with other enteric pathogens such as turkey coronavirus, rotavirus, or hemorrhagic enteritis virus [4, 7, 22, 29]. This immunosuppressive effect likely explains the high prevalence of co-infections observed in field studies, where TAstV is frequently detected alongside other viruses in flocks suffering from severe enteritis [4, 17, 26, 29].

Interspecies Transmission and Zoonotic Potential

The molecular pathogenesis of TAstV must also be considered in the context of its potential to cross species barriers. Serological surveys have detected antibodies against TAstV-2 in humans, particularly in individuals with occupational exposure to turkeys, such as abattoir workers and poultry growers [1]. The odds of seropositivity were approximately three times higher among abattoir workers compared to non-occupationally exposed individuals, suggesting that direct contact with infected turkeys or contaminated materials can lead to human exposure [1]. While no clinical disease has been definitively linked to TAstV infection in humans, the presence of specific antibodies indicates that the virus can replicate or at least present its antigens to the human immune system.

From a molecular perspective, the capsid protein's ability to function as an enterotoxin across species is supported by the observation that the TAstV-2 capsid can disrupt barrier function in human intestinal epithelial cell lines in vitro [12]. The receptor(s) for TAstV on human cells have not been identified, but the conservation of certain carbohydrate-binding domains in the capsid spike may allow for cross-species recognition. The World Health Organization (WHO) and the Food and Agriculture Organization (FAO) have emphasized the need for surveillance of emerging zoonotic pathogens in poultry production systems, and the detection of TAstV antibodies in humans underscores the importance of monitoring astrovirus evolution for potential pandemic threats. The high recombination rate and capsid hypervariability of TAstV provide the genetic plasticity necessary for host range expansion, and the close phylogenetic relationship between TAstV-2 and certain human astrovirus genotypes warrants continued vigilance [14].

Co-infection Dynamics and Synergistic Pathogenesis

In the field, TAstV rarely acts alone. Molecular surveys of turkey flocks affected by poult enteritis syndrome (PES) and poult enteritis complex (PEC) consistently reveal high rates of co-infection with other enteric viruses, including rotavirus, turkey coronavirus (TCoV), reovirus, and avian nephritis virus (ANV) [4, 17, 26, 29]. The molecular basis for these synergistic interactions likely involves multiple mechanisms. First, TAstV-induced disruption of the intestinal epithelial barrier facilitates the entry of co-infecting pathogens into the lamina propria, enhancing their ability to cause systemic disease. Second, TAstV-mediated immunosuppression through bursal and thymic atrophy impairs the host's ability to control concurrent infections, leading to higher viral loads and more severe pathology [3, 22]. Third, the osmotic diarrhea induced by TAstV capsid enterotoxin activity creates a favorable luminal environment for the replication of other enteric viruses, which may benefit from the increased fluid and electrolyte flux.

Experimental and field data support this model. In Brazilian turkey flocks, co-infections with TAstV-2 and TCoV were associated with more severe clinical signs and higher mortality than infections with either virus alone [4, 29]. Similarly, in Croatian flocks, the combination of TAstV-2 with hemorrhagic enteritis virus or avian reovirus resulted in more pronounced enteritis and growth suppression [22]. The molecular interplay between these viruses at the level of host cell signaling pathways, such as the activation of NF-κB, MAP kinases, and iNOS, likely amplifies the pathogenic response beyond what would be predicted from single infections. Understanding these co-infection dynamics is critical for developing effective control strategies, as vaccination against TAstV alone may not be sufficient to prevent disease in flocks where multiple enteric pathogens are circulating.

Age-Dependent Susceptibility and Intestinal Maturation

The molecular pathogenesis of TAstV is profoundly influenced by the age of the host. Epidemiological studies consistently demonstrate that young poults, particularly those between 1 and 4 weeks of age, are most susceptible to severe disease [13, 17]. In Polish turkey flocks, the prevalence of astrovirus infection was 82.1% in birds aged 1-4 weeks, compared to significantly lower rates in older birds [13]. This age-dependent susceptibility correlates with the maturation of the intestinal epithelium and the development of the gut-associated lymphoid tissue.

From a molecular perspective, the expression levels of NHE3 and other sodium transporters are developmentally regulated in the avian intestine. In neonatal poults, NHE3 expression is lower than in adults, and the capacity for sodium absorption is correspondingly reduced [18]. TAstV infection in these young birds, which further downregulates NHE3 through capsid-mediated internalization, may overwhelm the already limited absorptive capacity, leading to severe osmotic diarrhea and dehydration. Additionally, the immature immune system of young poults is less capable of mounting an effective adaptive response, allowing for higher viral replication and more prolonged shedding. The development of the gut microbiome also plays a role; the establishment of a diverse commensal microbiota in older birds may provide colonization resistance against TAstV or modulate the host immune response to limit pathogenesis. These age-related factors must be considered when designing experimental infection models and interpreting the results of pathogenicity studies.

Epidemiology of Turkey Astrovirus in Poultry and Humans

Turkey astrovirus (TAstV), encompassing both TAstV-1 and TAstV-2 genotypes, represents a pervasive and economically significant enteric pathogen of commercial poultry, with an epidemiological profile that is increasingly recognized as complex, multifactorial, and geographically expansive. The global distribution of TAstV is now well-documented across North America, Europe, South America, and the Middle East, yet the true prevalence is likely underestimated due to the high frequency of subclinical infections, frequent co-infections with other enteric viruses, and the reliance on molecular diagnostics that may not be uniformly applied in all production regions [16, 31]. The epidemiological landscape of TAstV is defined not only by its high prevalence in turkey flocks but also by its capacity for interspecies transmission, its association with a spectrum of clinical outcomes ranging from asymptomatic shedding to severe poult enteritis complex (PEC) and poult enteritis mortality syndrome (PEMS), and, critically, emerging evidence of zoonotic potential in occupationally exposed human populations [1, 14].

Prevalence and Global Distribution in Turkey Flocks

Comprehensive molecular surveys have established that TAstV infection is endemic in commercial turkey operations worldwide, with prevalence rates varying considerably based on geographic region, flock age, diagnostic methodology, and the clinical status of the birds. In a landmark cross-sectional study of Polish turkey flocks conducted between 2008 and 2011, astrovirus was detected in 44.9% (95% CI: 38.0-52.0) of 207 flocks sampled, with the highest prevalence observed in young turkeys aged 1-4 weeks (82.1%, 95% CI: 71.7-89.8) [13]. This age-dependent susceptibility is a consistent finding across epidemiological investigations and reflects the immunological naivety of young poults combined with the waning of maternally derived antibodies [13, 17]. A separate one-year molecular survey in Poland further corroborated these findings, detecting TAstV in 44.15% of 77 flocks, with TAstV-2 overwhelmingly predominant (38.9%) compared to TAstV-1 (11.6%), and avian nephritis virus (ANV) detected in only one flock [19].

In the Americas, the epidemiological burden is equally substantial. Studies in the United States, particularly in major turkey-producing states like Minnesota, have demonstrated that TAstV-2 is a nearly ubiquitous component of the poult enteritis syndrome (PES) etiological complex. One investigation of 43 PES cases using RT-PCR detected TAstV-2 in 84% of cases, often in combination with rotavirus (93%) and reovirus (40%), highlighting that mono-infections are the exception rather than the rule [26]. In Brazil, the epidemiological picture is striking for its high viral burden and complex co-infection dynamics. A comprehensive survey of 76 turkey flocks from multiple Brazilian states revealed that 93.4% of flocks were positive for at least one enteric virus, with TAstV-1 and TAstV-2 being among the most frequently detected agents [17]. Notably, in growing phase turkeys (1-4 weeks of age), an average of 3.20 viruses per sample was detected, with TAstV-1 and turkey coronavirus (TCoV) co-occurring in 85% of these samples [17]. Another Brazilian study focusing on flocks with severe enteritis found TAstV-2 in 8 of 22 flocks (36.4%), most commonly alongside TCoV and Lawsonia intracellularis [29]. The first detection of TAstV in Latin America was reported in Brazil in 2008, where RT-PCR of the capsid and polymerase genes confirmed TAstV-2 in all 100 cloacal swabs from poults with PEC, along with evidence of viral tropism for lymphoid tissues including the bursa of Fabricius, thymus, and spleen [3]. More recently, Ecuador has joined the list of affected nations, with a standardized RT-qPCR assay revealing TAstV detection in 93% of turkeys with gastroenteritis, with ANV being the most prevalent, followed by TAstV-2 and TAstV-1 [8]. This study also identified a high frequency of TAstV-2 and ANV co-infections, reinforcing the concept that these astroviruses rarely act in isolation [8].

In Europe and the Middle East, similar epidemiological patterns emerge. A Croatian investigation of 23 turkey flocks with clinical enteritis detected TAstV-2 in 17 of 23 intestinal content samples (73.9%), often co-occurring with hemorrhagic enteritis virus or avian reovirus, suggesting that immunosuppression may be a key factor in disease expression [22]. In Turkey (the country), a survey of flocks affected by PEMS detected TAstV in conjunction with TCoV and hemorrhagic enteritis virus, underscoring the multifactorial nature of severe enteric disease [7]. The presence of TAstV has also been confirmed in Nigeria, although a study of day-old commercial turkey poults in southwestern Nigeria detected chicken astrovirus (CAstV) in 83.5% of condemned or runted birds rather than TAstV, suggesting species-specific epidemiological partitioning or potential diagnostic cross-reactivity that warrants further investigation [10]. This finding is notable because it demonstrates that astroviruses from other avian species can circulate in turkey populations, complicating the epidemiological picture.

Age-Related Susceptibility and the Role of Co-Infections

A defining feature of TAstV epidemiology is the pronounced age-related susceptibility of young poults. The highest viral loads and most severe clinical outcomes are consistently observed in birds during the first four weeks of life, a period coinciding with intestinal maturation and the establishment of a stable gut microbiota [13, 17]. In the Polish cross-sectional study, the prevalence of astrovirus infection in turkeys aged 1-4 weeks was 82.1%, compared to significantly lower rates in older birds, and statistical modeling confirmed that age was a significant predictor of both astrovirus and rotavirus infection [13]. Similarly, Brazilian data revealed that growing phase turkeys (1-4 weeks) harbored an average of 3.20 viruses per sample, whereas finishing phase turkeys (5-18 weeks) had a lower average of 2.41 viruses per sample, with TAstV-1 and rotavirus being the most frequently detected agents in older birds [17]. This age-dependent decline in viral prevalence and diversity likely reflects the maturation of the adaptive immune response, competitive exclusion by a more stable microbiota, and the development of age-related resistance mechanisms.

The epidemiological significance of co-infections cannot be overstated. TAstV rarely circulates as a sole pathogen; rather, it is typically found in complex viral assemblages that include TCoV, rotavirus, reovirus, parvovirus, and ANV [16, 31]. In the aforementioned Polish study, 54 of 137 virus-positive flocks were co-infected with two different enteric viruses, and 9 flocks harbored three viruses simultaneously [13]. The most common co-infection patterns involve TAstV-2 with TCoV and rotavirus, particularly in flocks experiencing clinical enteritis [4, 26, 29]. Experimental evidence suggests that the pathogenicity of TAstV-2 can be modulated by the strain origin, with isolates from PES-affected flocks inducing more severe clinical signs, significant growth retardation, and bursal atrophy compared to isolates from apparently healthy flocks, providing a preliminary indication that pathogenic and non-pathogenic strains may co-circulate in the environment [2]. This strain-level variation in pathogenicity, combined with the potential for recombination events between different astrovirus strains as documented in US isolates [21], creates a dynamic epidemiological landscape wherein the emergence of novel, more virulent variants is a constant risk.

Zoonotic Potential and Human Epidemiology

Perhaps the most provocative and epidemiologically significant finding regarding TAstV is the emerging evidence of its zoonotic potential. Historically, astroviruses were considered strictly species-specific, but a growing body of evidence now supports the occurrence of cross-species transmission events [14]. A landmark serological study published in 2014 screened human sera from three distinct cohorts: a general population in Memphis, TN; a cohort in Chapel Hill, NC; and a group of Midwestern poultry abattoir workers, turkey growers, and non-occupationally exposed participants [1]. Using an enzyme-linked immunosorbent assay (ELISA) targeting TAstV-2, the study revealed that 26% of the Midwestern cohort was seropositive for TAstV-2 antibodies, compared to 0% and 8.9% in the other two cohorts [1]. Crucially, the odds of testing positive for TAstV-2 antibodies among abattoir workers were approximately 3 times higher than among other occupational groups within the same cohort, providing strong evidence of an occupational exposure risk [1]. This study demonstrated, for the first time, that humans with direct contact with turkeys can mount a serological response to TAstV-2, raising the critical question of whether this exposure results in active virus replication, clinical disease, or asymptomatic carriage.

The implications of these findings for public health and food safety are profound. The World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) have long recognized that zoonotic enteric pathogens represent a significant and underappreciated burden on global health, particularly in agricultural settings. The demonstration of TAstV-2 seropositivity in poultry workers aligns with the broader recognition that astroviruses, including human astroviruses, are among the most common causes of viral gastroenteritis in children and immunocompromised individuals worldwide, second only to rotavirus [14, 30]. While the study did not establish whether seropositive individuals experienced clinical disease, the detection of antibodies indicates exposure and immune recognition. The capsid protein of TAstV-2 has been shown to possess intrinsic enterotoxic activity, inducing dose-dependent acute diarrhea in turkey poults through disruption of intestinal barrier function and redistribution of sodium-hydrogen exchanger 3 (NHE3), independent of viral replication [12, 18]. This enterotoxin-like activity raises the possibility that even non-infectious exposure to TAstV capsid protein, perhaps through aerosolized feces in abattoir environments, could theoretically contribute to gastrointestinal symptoms in exposed workers.

The broader context of astrovirus interspecies transmission includes documented recombination events between turkey astroviruses and astroviruses from other avian species, such as goose astrovirus (GAstV). Phylogenetic analyses have revealed that GAstV-2 strains isolated from goslings with fatal gout in China contain recombination events at the 3' end of the genome between GAstV TZ03 and Turkey astrovirus CA/00, demonstrating that TAstV genetic material can become incorporated into the genomes of astroviruses circulating in other host species [5]. Similarly, GAstV group II strains have been classified alongside duck astrovirus II and turkey astrovirus II, indicating shared ancestry and potential for cross-species adaptation [9]. The detection of a novel astrovirus in a black-naped monarch (Hypothymis azurea) in Cambodia, which forms a distinct lineage but clusters within the avastrovirus group, further emphasizes the diversity and host range of these viruses [15]. Ruddy turnstones (Arenaria interpres) in Brazil have also been found to harbor novel astroviruses that group phylogenetically with poultry astroviruses, including those from chickens, geese, and turkeys, suggesting that migratory birds may serve as vectors for the long-distance dissemination of astroviruses [11].

The epidemiological surveillance of TAstV in human populations remains in its infancy, but the available data underscore an urgent need for expanded monitoring, particularly in occupational settings such as poultry processing plants, hatcheries, and farms. The World Organisation for Animal Health (WOAH) recognizes the importance of monitoring emerging zoonotic pathogens in livestock populations, and the case of TAstV highlights the necessity of a One Health approach that integrates veterinary, environmental, and human health surveillance. The genetic plasticity of astroviruses, driven by high mutation rates, recombination, and the potential for interspecies transmission, means that the emergence of a fully zoonotic strain capable of sustained human-to-human transmission cannot be dismissed as a hypothetical risk [14]. The high prevalence of TAstV in poultry populations worldwide, combined with the demonstrated serological response in exposed humans, establishes this virus as a pathogen of dual concern for both agricultural productivity and public health security.

Clinical Manifestations and Pathogenicity in Turkey Poults

The clinical trajectory of turkey astrovirus (TAstV) infection in poults is a subject of profound complexity, defined not by a singular, uniform disease phenotype but rather by a spectrum of manifestations that range from subclinical, self-limiting enteritis to severe, often fatal, enteric syndromes. The pathogenicity of TAstV is inextricably linked to host age, viral strain, environmental stressors, and the ubiquitous presence of co-infecting pathogens. Understanding this nuanced clinical picture is paramount for accurate diagnosis, effective management, and the development of robust control strategies for this economically significant pathogen.

The Clinical Spectrum: From Enteritis to Mortality Syndromes

The most overt clinical sign associated with TAstV infection in commercial turkey flocks is diarrhea, which serves as the sentinel indicator of enteric disease. This is not a uniform phenomenon; the character of the diarrhea can vary significantly. In acute cases, poults present with profuse, watery to foamy feces, often described as light brown or yellow in color, a hallmark of the poult enteritis mortality syndrome (PEMS) complex [32]. This rapid-onset, high-volume diarrhea is a primary driver of the dehydration and electrolyte imbalances that can quickly lead to morbidity and mortality, particularly in young poults less than three weeks of age. Conversely, in less acute presentations associated with poult enteritis syndrome (PES) or poult enteritis complex (PEC), the diarrhea may be less voluminous but more persistent, characterized by pasty, mucoid, or undigested fecal material [2]. This chronic enteritis leads to a failure to thrive, manifesting as depression, dullness, ruffled feathers, and a characteristic huddling behavior as poults seek to conserve energy [2]. The impact on growth is perhaps the most economically devastating consequence. Experimentally, poults infected with a pathogenic field strain of TAstV-2 from PES-affected flocks exhibited a statistically significant reduction in body weight by 16 days post-inoculation (dpi) compared to both mock-infected controls and birds infected with a less pathogenic strain from an apparently healthy flock [2]. This growth retardation is a direct consequence of the malabsorptive and maldigestive state induced by the virus, leading to poor feed conversion ratios and significant economic losses for producers, a concern echoed by the World Organisation for Animal Health (WOAH) in its surveillance of production-limiting diseases.

The Molecular Pathobiology of Diarrhea and Malabsorption

A defining and remarkable feature of TAstV pathogenesis, setting it apart from many other enteric viruses like rotavirus or coronavirus, is the absence of a robust inflammatory response or significant histological tissue destruction at the light microscopy level [12, 18]. The diarrhea is not a result of villous atrophy, cellular necrosis, or an influx of inflammatory cells. Instead, TAstV induces a functional, non-inflammatory secretory-malabsorptive diarrhea rooted in subtle but critical subcellular derangements. In vitro studies in differentiated human intestinal Caco-2 cell lines provided the initial mechanistic clues, demonstrating that the TAstV-2 capsid protein alone, independent of viral replication, can disrupt the actin cytoskeleton and tight junction complex, thereby increasing paracellular permeability [12]. This finding was dramatically confirmed in vivo, where the oral administration of purified, non-infectious recombinant TAstV-2 capsid protein to turkey poults was sufficient to induce acute, dose-dependent diarrhea [12]. This identifies the capsid as a viral enterotoxin, a functional parallel to the rotavirus NSP4 protein and a critical virulence factor that allows the virus to cause disease even in the absence of a lytic replication cycle.

The mechanistic underpinnings of this capsid-induced diarrhea have been further elucidated through electrophysiological and molecular studies. TAstV-2 infection profoundly alters ion transport across the intestinal epithelium, specifically inducing sodium malabsorption [18]. This is achieved via the redistribution of key sodium transporters, most notably the sodium/hydrogen exchanger 3 (NHE3). In a healthy gut, NHE3 is localized to the apical membrane of enterocytes, where it facilitates the electroneutral absorption of dietary sodium, driving water absorption. TAstV infection causes a dramatic internalization of NHE3 from the brush border membrane into the cytoplasm of the epithelial cells, effectively rendering it non-functional [12, 18]. The consequent failure to absorb sodium creates an osmotic gradient that draws water into the intestinal lumen, producing the hallmark watery diarrhea. This pathophysiology is consistent with the clinical observation that the diarrhea is osmotic in nature and explains the lack of inflammation; the immune system is not responding to a pathogen-induced cytopathic effect, but rather to the consequences of a physiological transport failure triggered by a viral enterotoxin.

Systemic Effects and Immunopathogenesis

While the most prominent clinical signs are gastrointestinal, TAstV infection is not confined to the gut. The virus exhibits a significant tropism for lymphoid tissues, including the bursa of Fabricius, thymus, and spleen, leading to a state of transient immunosuppression that has major implications for flock health [3]. In birds suffering from poult enteritis complex (PEC), histological examination of these organs reveals severe pathological changes: the bursa of Fabricius shows significant atrophy with lymphoid depletion and follicular necrosis; the thymus demonstrates cortical atrophy and lymphocyte depletion; and the spleen exhibits lymphoid depletion and reticular cell hyperplasia [3]. This lymphoid atrophy is a direct pathogenic effect of the virus replicating within these tissues, leading to a reduction in both B-cell and T-cell populations. This immunosuppressive effect is pathogenically significant. It not only exacerbates the primary enteric disease but also renders poults highly susceptible to secondary bacterial and viral infections, a critical factor in the multifactorial nature of PES and PEMS. The co-infection with other agents, as documented extensively, is the rule rather than the exception. In one study of PES cases in Minnesota, for example, only 19% of cases involved a single virus detected by RT-PCR, while a staggering 81% involved co-infections of TAstV-2 with rotavirus and/or reovirus [26]. Similarly, in flocks affected with poult enteritis, TAstV-2 is frequently found alongside turkey coronavirus (TCoV), hemorrhagic enteritis virus (HEV), and avian reovirus, with the combination of TAstV-2, HEV, and reovirus being associated with particularly severe disease and mortality [22]. These co-infections create a "one-two punch": the astrovirus initiates the enteric dysfunction and immunosuppression, and the co-infecting agent precipitates a more severe, often fatal, clinical outcome. The host’s innate immune response also plays a dual role. While the induction of inducible nitric oxide synthase (iNOS) in intestinal epithelial cells represents an antiviral defense mechanism, the production of nitric oxide (NO) can also contribute to tissue pathology and intestinal barrier dysfunction, adding another layer of complexity to the pathogenesis [28].

Strain Variation and the Determinants of Virulence

A critical observation from both field and experimental studies is that not all TAstV strains are created equal. Significant differences in pathogenicity exist, suggesting the presence of distinct pathotypes circulating in turkey populations. This was elegantly demonstrated in a controlled experiment where 7-day-old poults were inoculated with TAstV-2-positive intestinal contents originating from either clinically affected PES flocks or from flocks that were apparently healthy, testing positive for the virus but showing no signs of disease [2]. While both groups shed virus in their feces and developed mild clinical signs, the PES-derived strain induced significantly more severe pathology: the birds exhibited pronounced depression and diarrhea, a profound and statistically significant reduction in body weight, and a measurable reduction in bursa size compared to those infected with the "healthy" strain [2]. This finding provides compelling evidence that strain-specific genetic determinants are a primary driver of virulence. The genetic basis for these differences is likely found in the capsid (ORF2) and polymerase (ORF1b) genes, which display a high degree of variability. US isolates of TAstV collected between 2003 and 2004 showed as little as 69% nucleotide identity in the capsid gene, and isolates from different houses on the same farm could have as little as 72% identity [21]. This genetic hypervariability, combined with the demonstrated potential for recombination between different astrovirus species, as seen between TAstV and goose astrovirus (GAstV) [5, 24], creates a dynamic landscape from which novel, potentially more pathogenic strains can emerge. This inherent genetic plasticity poses a continuous challenge for diagnosis, surveillance, and the development of broadly protective vaccines, a concern that aligns with the Centers for Disease Control and Prevention's (CDC) emphasis on monitoring emerging viral variants.

Age-Related Susceptibility and Epidemiological Patterns

The clinical severity of TAstV infection is inversely correlated with age. The highest prevalence and most severe clinical signs are consistently observed in young poults, particularly those in the 1- to 4-week age range [13, 17]. This period of heightened susceptibility coincides with the waning of maternally derived antibodies and the functional immaturity of the poult's own immune system, including the bursa and thymus, which are prime targets for the virus. Epidemiological surveys confirm this pattern. In Polish turkey flocks, the prevalence of astrovirus infection was highest in the youngest birds, with 82.1% of flocks aged 1-4 weeks testing positive for at least one enteric virus, a rate that declined significantly in older birds [13]. Similarly, in Brazilian flocks, growing-phase turkeys (1-4 weeks) showed the highest positivity rates for enteric viruses, including TAstV-1 and TAstV-2, with an average of over three viruses detected per sample in some cases [17]. The age-dependent pathogenicity is also a major factor in the clinical presentation of PEMS, which typically affects poults between 7 and 28 days of age, and PEC, which is most problematic in the first 6 weeks of life. The poult's immature gut flora, developing digestive enzyme system, and lack of prior exposure to viral antigens all contribute to this window of high vulnerability. Furthermore, high ambient temperatures and low humidity, as seen in tropical climates, can act as environmental stressors that exacerbate the clinical severity of TAstV infection, increasing the risk of disease transmission and severity [32]. The remarkable epidemiological picture of widespread subclinical infections in older birds serves as a constant reservoir for infection of the highly susceptible young poults, perpetuating the cycle of disease on turkey farms worldwide.

Zoonotic Considerations and Human Exposure

The implications of TAstV infection extend beyond the farm gate, raising important questions about its zoonotic potential. While historically considered strictly species-specific, an increasing body of evidence, including the source manuscripts for this section, challenges that dogma [1, 14]. Astroviruses are known for their genetic plasticity and ability to jump species barriers, and TAstV is no exception. The detection of antibodies against TAstV-2 in human sera is a landmark finding that underscores this risk [1]. In a serosurvey of three distinct human cohorts, including poultry abattoir workers, turkey growers, and a control population, 26% of one cohort tested positive for antibodies to TAstV-2. Critically, the odds of seropositivity were three times higher among abattoir workers than in other groups, providing strong evidence of occupational exposure and a humoral immune response in humans [1]. While this study did not determine if this exposure leads to active viral replication or clinical disease in humans, it raises a profound public health question. The mechanism of interspecies transmission is plausible given the structural similarity of the astrovirus capsid and its ability to bind to receptors across species. The high prevalence of TAstV in turkey flocks (44.9% of flocks in one Polish study [13] and 93% in a later Ecuadorian study on sick birds [8]) means that abattoir workers and others in close contact with live birds or raw poultry products are frequently and heavily exposed. This observation aligns with the World Health Organization’s (WHO) "One Health" approach, which recognizes that the health of humans, animals, and the environment are interconnected. While TAstV is not currently classified as a major zoonotic threat, the documented seroconversion in humans [1] and the known potential for astrovirus recombination and adaptation [14] necessitate ongoing surveillance to monitor for any signs of adaptation to a human host or the emergence of a human-pathogenic strain. This potential for cross-species transmission adds a critical layer of significance to the study of this virus in its natural avian host.

Zoonotic Potential and Serological Evidence in Humans

The question of whether turkey astrovirus (TAstV) possesses a genuine zoonotic potential represents one of the most compelling and contentious frontiers in astrovirus research. Historically, the Astroviridae family was regarded as strictly species-specific, with distinct genotypes circulating within defined mammalian or avian hosts and exhibiting little capacity for cross-species transmission. This paradigm has been fundamentally challenged over the past decade by accumulating molecular, serological, and epidemiological evidence. For turkey astrovirus, the investigation into human infection is not merely an academic exercise; it carries profound implications for public health surveillance, occupational medicine, food safety, and our understanding of viral emergence from agricultural reservoirs. The World Health Organization (WHO) and the Food and Agriculture Organization (FAO) have increasingly emphasized the need to monitor zoonotic pathogens at the human-animal interface, particularly within intensive livestock production systems where dense animal populations and frequent human contact create ideal conditions for viral spillover.

The Foundational Serological Evidence: The Meliopoulos et al. (2014) Study

The single most critical piece of evidence regarding the zoonotic potential of TAstV originates from a landmark serosurvey conducted by Meliopoulos and colleagues, published in 2014 [1]. This study represents the first and, to date, most comprehensive attempt to directly assess human exposure to turkey astrovirus. The investigators employed a highly specific enzyme-linked immunosorbent assay (ELISA) based on recombinant TAstV-2 capsid protein to screen sera from three distinct human cohorts. The cohorts were carefully selected to represent varying degrees of potential exposure: a general population cohort from Memphis, Tennessee; a cohort from Chapel Hill, North Carolina; and a critical third cohort composed of individuals from the Midwestern United States, a region with a high density of commercial turkey production. This third cohort was further stratified into abattoir workers, turkey growers, and non-occupationally exposed participants living in the same geographic area.

The results were striking and paradigm-shifting. While the Memphis and Chapel Hill cohorts showed seropositivity rates of 0% and 8.9%, respectively, the Midwestern cohort exhibited a seroprevalence of 26% [1]. This dramatic disparity immediately suggested that geographic proximity to turkey production and, more specifically, direct occupational contact with turkeys were significant risk factors for seroconversion. The study’s most compelling finding was the calculation of odds ratios: abattoir workers had approximately three times higher odds of testing positive for antibodies against TAstV-2 compared to other groups within the same cohort [1]. This dose-response relationship between intensity of exposure and seropositivity provides strong epidemiological evidence for a causal link between contact with turkeys and the development of a humoral immune response to TAstV-2.

It is crucial to dissect the biological implications of these serological findings. The detection of antibodies against a viral capsid protein indicates that the human immune system has encountered the virus or a highly antigenically similar agent. The capsid protein is the primary structural component of the virion and the main target of the host adaptive immune response. Therefore, the presence of anti-TAstV-2 capsid antibodies strongly suggests that viral replication occurred within these human subjects, as a sterile, non-replicating exposure to inactivated viral particles would be unlikely to generate a robust, sustained antibody response detectable by ELISA. However, the study authors were appropriately cautious, explicitly stating that further work is needed to determine if these exposures result in virus replication and/or clinical disease [1]. The critical distinction between serological evidence of exposure and proof of productive infection with clinical consequences cannot be overstated. Nonetheless, this study established that the human immune system is capable of recognizing and responding to TAstV-2 antigens, breaking the long-held assumption of strict species specificity.

Biological Plausibility: Mechanisms Facilitating Cross-Species Transmission

The serological findings of Meliopoulos et al. are not biologically isolated; they are supported by a growing body of evidence demonstrating that astroviruses, as a family, possess a remarkable propensity for interspecies transmission and genetic recombination. A comprehensive review by Benedictis et al. (2011) synthesized the existing knowledge on astrovirus molecular biology and genetic diversity, explicitly highlighting the increasing evidence of cross-species transmission and the potential for zoonotic emergence [14]. The authors noted that the wide variety of species infected, the evident virus genetic diversity, and the frequent occurrence of recombination events all indicate that astroviruses are capable of jumping species barriers and adapting to new hosts [14]. This inherent genetic plasticity is a hallmark of emerging RNA viruses and provides the mechanistic foundation for the serological observations in humans.

Further supporting this biological plausibility is the well-documented phenomenon of recombination within turkey astroviruses themselves. Pantin-Jackwood et al. (2006) provided definitive phylogenetic evidence of recombination events occurring between TAstV strains circulating in commercial turkey flocks, demonstrating that the capsid and polymerase genes can have distinct evolutionary histories [21]. This capacity for genetic exchange can generate novel viral variants with altered host tropism or antigenic profiles. More recently, Xu et al. (2024) identified a recombination event between a goose astrovirus (GAstV) strain and turkey astrovirus CA/00, occurring within the 3′ end of the genome [5]. This finding demonstrates that recombination is not confined to within-species interactions but can occur between different avian astrovirus species, further blurring the lines of host specificity. If TAstV can recombine with goose astroviruses, the possibility of recombination with mammalian astroviruses, including human strains, cannot be dismissed. The emergence of novel astroviruses in other avian species, such as the detection of an astrovirus in a black-naped monarch in Cambodia that formed a distinct fourth avastrovirus group [15], and the identification of ruddy turnstone astrovirus in migratory birds in Brazil [11], underscores the vast, largely unexplored reservoir of astrovirus diversity in wild birds. These wild birds could act as bridging hosts, facilitating the introduction of novel astroviruses into poultry populations and, subsequently, into humans.

The Capsid Protein as an Enterotoxin: Implications for Human Disease

A critical piece of the puzzle regarding the potential clinical consequences of TAstV infection in humans comes from the work of Meliopoulos et al. (2016), which demonstrated that the TAstV-2 capsid protein itself possesses intrinsic enterotoxigenic activity [12]. In a series of elegant experiments, the authors showed that oral administration of purified recombinant TAstV-2 capsid protein to turkey poults was sufficient to induce acute diarrhea in a dose- and time-dependent manner, independent of viral replication [12]. This diarrhea was associated with increased intestinal barrier permeability and redistribution of the sodium hydrogen exchanger 3 (NHE3) from the membrane to the cytoplasm of intestinal epithelial cells, leading to sodium malabsorption and osmotic diarrhea [12, 18]. This mechanism is strikingly similar to the enterotoxigenic activity of the rotavirus nonstructural protein NSP4, suggesting that astroviruses may employ a conserved pathogenic strategy.

The implications of this finding for zoonotic potential are profound. If the TAstV-2 capsid protein can act as an enterotoxin in the absence of viral replication, then even a non-productive exposure to the virus, such as ingestion of contaminated material, could theoretically trigger diarrheal disease in humans. This mechanism could explain the serological evidence of exposure in abattoir workers [1], who may be exposed to high concentrations of viral particles and capsid proteins through aerosolized fecal dust or contaminated surfaces. The capsid protein is remarkably stable, as astroviruses are non-enveloped viruses resistant to environmental degradation. The study by Nighot et al. (2010) further elucidated the cellular mechanisms, demonstrating that TAstV-2 infection induces rearrangement of F-actin and redistribution of NHE3, leading to decreased sodium absorption [18]. These findings collectively suggest that the pathogenic mechanisms of TAstV are mediated by the capsid protein and are conserved across species, raising the distinct possibility that similar pathophysiological processes could occur in the human intestine upon exposure to the virus or its capsid.

Epidemiological Context and Occupational Risk

The epidemiological data from the Meliopoulos et al. study must be interpreted within the broader context of occupational health in the poultry industry. The finding that abattoir workers had three times higher odds of seropositivity compared to other groups [1] highlights a clear occupational risk. Workers in turkey processing plants are exposed to a complex mixture of biological hazards, including fecal material, respiratory secretions, and blood, often in high concentrations and for extended periods. The detection of TAstV-2 antibodies in this population suggests that current biosecurity and personal protective equipment (PPE) protocols may be insufficient to prevent exposure to avian enteric viruses. This is particularly concerning given that the study also detected seropositivity in non-occupationally exposed participants living in the same Midwestern region [1], indicating that environmental contamination or indirect exposure may also occur. The WHO has identified occupational exposure to livestock as a key risk factor for the emergence of novel zoonotic diseases, and these findings underscore the need for enhanced surveillance and protective measures in the poultry industry.

It is important to note that the seroprevalence of 0% in the Memphis cohort and 8.9% in the Chapel Hill cohort [1] likely reflects the general population background exposure to astroviruses. Human astroviruses (HAstV) are a leading cause of gastroenteritis in children and immunocompromised individuals worldwide, with seroprevalence rates approaching 100% in adults [14, 30]. The low-level seropositivity in the Chapel Hill cohort could represent cross-reactivity with human astrovirus antibodies, given that the ELISA used TAstV-2 capsid protein. However, the significantly higher seroprevalence in the occupationally exposed cohort, coupled with the dose-response relationship, argues strongly against cross-reactivity as the sole explanation. The study by Aktaş et al. (2019) in children with gastroenteritis in Turkey found that 5.6% of samples were positive for astrovirus by RT-PCR [30], highlighting the endemic nature of human astrovirus infections. The challenge for future research will be to develop serological assays that can definitively distinguish between antibodies elicited by human astrovirus infection and those elicited by exposure to turkey astrovirus.

Gaps in Knowledge and Future Directions

Despite the compelling serological evidence, significant gaps remain in our understanding of the zoonotic potential of TAstV. The most critical unanswered question is whether TAstV can productively replicate in human cells and cause clinical disease. The Meliopoulos et al. study did not attempt to isolate virus from seropositive individuals or to detect viral RNA in human clinical samples [1]. Without direct evidence of viral replication, the possibility remains that the observed antibodies are the result of repeated exposure to non-infectious viral antigens, such as capsid protein in contaminated food or water, rather than a true infection. The demonstration that capsid protein alone can induce diarrhea in turkeys [12] suggests that even non-productive exposure could have clinical consequences, but this has not been tested in humans.

Furthermore, the study did not investigate whether seropositive individuals experienced any gastrointestinal symptoms or other clinical manifestations. A prospective cohort study of abattoir workers, combining serological monitoring with symptom diaries and molecular detection of TAstV in stool samples, would be invaluable. Such a study could determine the incidence of TAstV infection, the duration of viral shedding, and the association with clinical disease. Additionally, in vitro studies using human intestinal organoids or differentiated Caco-2 cell lines could assess the permissiveness of human cells to TAstV infection and replication. The work of Meliopoulos et al. (2016) using Caco-2 cells to study human astrovirus capsid effects [12] provides a template for such investigations. Finally, the potential for TAstV to cause disease in immunocompromised individuals, who are known to be susceptible to severe and persistent astrovirus infections, warrants investigation. The World Organisation for Animal Health (WOAH) recognizes the importance of monitoring emerging diseases at the human-animal interface, and TAstV should be considered a candidate pathogen for such surveillance programs.

Diagnostics and Detection Methods for Turkey Astrovirus

The accurate and timely detection of turkey astrovirus (TAstV) is paramount for understanding its epidemiology, controlling outbreaks of poult enteritis complex (PEC) and poult enteritis mortality syndrome (PEMS), and assessing the potential for interspecies transmission, including zoonotic implications noted by global health authorities such as the World Health Organization (WHO) and the Food and Agriculture Organization (FAO) under a One Health framework [1, 14]. The diagnostic landscape for TAstV has evolved from classical virological techniques to highly sensitive molecular platforms, yet each method carries distinct advantages and limitations shaped by the virus’s intrinsic genetic diversity, its frequent co-occurrence with other enteric pathogens, and the complex clinical presentations of enteric disease in turkey flocks.

Historical and Classical Detection Methods

Before the advent of molecular diagnostics, detection of astroviruses relied on electron microscopy (EM) and immune-based assays. Early work by Saif et al. [23] identified a small (18–24 nm) round virus, now recognized as TAstV, in gut contents from poults with enteritis using EM. This technique, while useful for morphological identification, suffers from low sensitivity, requiring high viral loads (~10⁶ particles/mL), and cannot differentiate among astrovirus types or distinguish them from other small round viruses. Jindal et al. [26] demonstrated the stark contrast between EM and reverse transcription–polymerase chain reaction (RT-PCR): of 43 poult enteritis syndrome (PES) cases, only 13 were positive for small round viruses by EM, whereas RT-PCR detected TAstV-2 in 36 cases (84%). This underscores the inadequacy of EM for routine surveillance or early outbreak detection. Virus isolation, attempted using embryonated eggs or cell cultures, has proven challenging for TAstV. Early reports note that detection and diagnosis in non-human hosts relied heavily on EM and fluorescent antibody (FA) tests [20]. In more recent studies, isolation of related avastroviruses, such as goose astrovirus in LMH cells [5], has been successful, but no robust continuous cell culture system for TAstV has been widely adopted, limiting its utility for primary diagnostics.

Molecular Detection: Reverse Transcription Polymerase Chain Reaction (RT-PCR)

RT-PCR has become the cornerstone of TAstV detection, offering superior sensitivity, specificity, and the ability to type and genotype viral strains. The first dedicated RT-PCR for TAstV was developed by Koci et al. [20], targeting conserved regions of the viral capsid and polymerase genes. This seminal work enabled detection of astrovirus RNA in commercial turkey flocks and laid the foundation for subsequent epidemiological studies. Since then, a plethora of RT-PCR assays have been designed, primarily amplifying segments of the RNA-dependent RNA polymerase gene (ORF1b) and the capsid protein gene (ORF2). The choice of target has important implications: ORF1b is generally more conserved across astrovirus types, making it suitable for broad detection, whereas ORF2 is hypervariable and essential for genotyping and phylogenetic analysis [21]. For instance, Silva et al. [3] applied RT-PCR targeting both the capsid and polymerase genes to bursa of Fabricius, thymus, spleen, and cloacal swabs from poults with PEC in Brazil. They found that 5 out of 10 thymus and spleen samples negative by polymerase-gene RT-PCR became positive when capsid-specific primers were used, highlighting that different gene targets can yield discrepant results due to sequence variability or recombination.

Multiplex and panel-based RT-PCR approaches have been adopted to address the frequent polymicrobial nature of turkey enteritis. Several large surveys have employed RT-PCR for simultaneous detection of TAstV-1, TAstV-2, avian nephritis virus (ANV), turkey coronavirus, rotavirus, reovirus, parvovirus, and adenovirus [13, 17, 22, 29]. These studies reveal that single infections are rare; for example, in a Brazilian survey of 76 flocks, 69.7% of samples were positive for more than one virus, and TAstV-1 and TCoV were detected together in 85% of growing-phase turkeys [17]. Such multiplexing is critical because co-infections may exacerbate clinical signs and complicate interpretation of etiological roles. However, primer competition and differential amplification efficiencies require careful optimization. Streck et al. [32] compared simplex and multiplex RT-PCR for TAstV-2 and TCoV, finding that multiplex formats had 3.98 times greater odds of yielding positive results from faeces compared to cloacal swabs during dry season, presumably due to higher viral load or reduced inhibitors.

Quantitative and Real-Time RT-PCR (RT‑qPCR)

The development of quantitative RT‑qPCR has allowed not only detection but also viral load quantification, enabling studies of pathogenesis, shedding dynamics, and vaccine efficacy. Loor-Giler et al. [8] standardized SYBR Green‑based RT‑qPCR assays for TAstV‑1, TAstV‑2, and ANV in Ecuador. Their assays achieved a limit of detection of one copy of viral genetic material, with inter- and intra-assay coefficients of variation below 1%, demonstrating exceptional repeatability. When applied to field samples, these RT‑qPCR tests detected TAstV in 93% of turkeys with gastroenteritis, compared to 0% in apparently healthy birds. Quantitative data can distinguish between high-level shedding associated with active disease and low-level background carriage common in older flocks [13]. Nonetheless, the genetic diversity of astroviruses, especially in the capsid gene, poses a risk of primer-template mismatch, which can lead to underestimation of prevalence. Domańska-Blicharz et al. [19] emphasized this point, noting that due to high sequence variability, the most reliable method for typing Polish TAstV strains was sequencing rather than relying solely on type-specific RT-PCR.

Serological Detection: ELISA and Antibody Surveillance

While molecular methods dominate virus detection, serological assays provide complementary information on exposure history and immune status. The most notable serological work relevant to TAstV comes from Meliopoulos et al. [1], who developed an enzyme‑linked immunosorbent assay (ELISA) using recombinant TAstV‑2 capsid protein to screen human sera. They found that 26% of a cohort with turkey exposure (abattoir workers, growers, and non‑occupationally exposed participants) were seropositive, compared to 0–8.9% in other cohorts. This study not only revealed potential zoonotic transmission but also demonstrated that TAstV‑2 capsid protein elicits a detectable antibody response in an incidental host. Despite this, routine serological monitoring in turkey flocks is less common than molecular detection. No licensed commercial ELISA for TAstV is currently available, and studies using in‑house assays have been limited. The absence of a standardized serological test hampers large‑scale surveillance required by organizations such as the World Organisation for Animal Health (WOAH) to assess the global burden of avian astrovirus infections. Future development of species‑specific and type‑specific ELISAs would greatly facilitate epidemiological studies and assessment of maternal antibody transfer.

Sequencing and Phylogenetic Analysis: Unmasking Genetic Diversity and Recombination

Sequencing of RT‑PCR amplicons has become indispensable for understanding TAstV evolution, genotyping, and detection of recombination events. Pantin‑Jackwood et al. [21] sequenced the capsid and polymerase genes of 23 U.S. TAstV isolates and found nucleotide identity as low as 69% in the capsid gene among isolates from the same farm, whereas the polymerase gene was more conserved (86–99% identity). Differences in phylogenetic topologies between the two genes provided strong evidence of recombination, a mechanism that generates novel strains and may facilitate host switching. Similarly, Xu et al. [5] identified a recombination event between goose astrovirus and TAstV (strain CA/00) in novel goose astrovirus isolates, underscoring the role of cross‑species genetic exchange. Full‑genome sequencing, as performed for goose astrovirus [9, 24] and avian nephritis virus [25], provides the highest resolution for characterizing emerging strains and mapping evolutionary dynamics. For routine diagnostics, partial sequencing of ORF1b (e.g., 432‑bp fragment) has been used for phylogenetic placement of bovine and turkey astroviruses [6, 33], but the capsid gene is recommended for detailed strain discrimination [19].

Challenges and Future Directions in TAstV Diagnostics

Several obstacles complicate TAstV detection. First, high genetic variability requires the use of degenerate primers or multiple primer sets to avoid false negatives. For example, Domańska‑Blicharz et al. [19] used four different primer pairs within the RdRp gene to capture the diversity of Polish TAstV strains. Second, the frequent co‑infection with other enteric viruses (rotavirus, coronavirus, reovirus, parvovirus [13, 26, 31]) confounds attribution of clinical signs to TAstV alone. Multiplex and metagenomic approaches are increasingly necessary to disentangle this polymicrobial etiology. Third, sample type and storage conditions influence detection. Cloacal swabs, faeces, and intestinal contents yield different sensitivities; Streck et al. [32] showed that ileum‑caeca region had higher odds of positivity than faeces in simplex RT‑PCR. Seasonality also plays a role, with low humidity and high temperatures favouring viral spread and detection [32]. Finally, the zoonotic potential demonstrated by serological evidence [1] calls for integrated human–animal surveillance, aligning with WHO and FAO One Health initiatives. Next‑generation sequencing and metagenomics, as used to discover novel astroviruses in ruddy turnstones [11] and to characterize ANV‑3 [25], represent the future of unbiased pathogen discovery, but their cost and complexity currently limit routine application in diagnostic laboratories. Standardization of RT‑qPCR methods, as pioneered by Loor‑Giler et al. [8], and widespread adoption of sequencing for molecular epidemiology will be essential to control TAstV‑associated disease and mitigate risks to both turkey production and public health.

Prevention and Control Strategies for Turkey Astrovirus Infections

The prevention and control of turkey astrovirus (TAstV) infections, encompassing both type 1 (TAstV-1) and type 2 (TAstV-2), as well as related avian nephritis virus (ANV), represents a formidable challenge for the global turkey industry. The complexities of managing this pathogen arise from its high genetic diversity, its ubiquitous nature in production environments, its capacity for recombination, and its frequent involvement in multifactorial enteric disease complexes such as Poult Enteritis Complex (PEC) and Poult Enteritis Mortality Syndrome (PEMS) [4, 7, 16, 22]. Effective control mandates a multi-layered approach that integrates rigorous biosecurity, sensitive and specific diagnostic surveillance, strategic immune-based interventions, and meticulous environmental management. The economic imperative for these strategies is underscored by the documented impacts on growth retardation, poor feed conversion, increased mortality, and the immunosuppressive consequences that predispose flocks to secondary infections [2, 3, 17].

Foundational Principles of Biosecurity and Management

The cornerstone of any astrovirus control program is the prevention of viral introduction into a naïve flock and the reduction of viral load in endemic environments. TAstV is shed in high titers in the feces of infected poults, often before clinical signs are evident, creating a constant reservoir of infectious material [2, 26]. The virus's non-enveloped structure confers significant environmental stability, allowing it to persist on fomites, in litter, and in dust, thereby facilitating both horizontal and indirect transmission [8, 31]. Therefore, biosecurity protocols must be exceptionally robust.

All-in/All-out Management and Facility Decontamination: Complete depopulation followed by thorough cleaning and disinfection is non-negotiable. Given the virus's resilience, standard disinfection protocols may be insufficient. The use of oxidizing agents (e.g., peroxygen compounds), aldehydes, or high concentrations of chlorine-based disinfectants is recommended, with attention to contact times and organic matter removal. The World Organisation for Animal Health (WOAH) guidelines for non-enveloped virus inactivation should be consulted to validate disinfection efficacy. Following cleaning, a period of downtime, typically a minimum of two weeks, though longer may be beneficial, is critical to allow residual viral RNA and infectious particles to degrade. The evidence for this necessity comes from studies showing that the virus can be detected in flocks with no direct contact, suggesting airborne or fomite spread [32].

Control of the Production Environment: Environmental risk factors have been empirically linked to TAstV transmission. Research from tropical and subtropical regions, such as Brazil, has identified that periods of low humidity and high ambient temperatures, common during winter in certain latitudes, significantly increase the odds of detecting TAstV and TCoV in flocks [32]. These conditions may favor aerosolization of fecal dust and reduce viral decay rates outside the host. Consequently, environmental control within poultry houses should focus on maintaining optimal ventilation to reduce dust and ammonia levels, managing litter moisture to minimize dust generation, and controlling temperature fluctuations. While specific THI (Temperature-Humidity Index) thresholds for TAstV are not defined, maintaining conditions that reduce environmental stress on poults is a prudent strategy, as stress can exacerbate disease severity [17, 22].

Zoonotic Considerations for Personnel: A critical and often overlooked aspect of biosecurity is the protection of farm and abattoir personnel. Compelling serological evidence from the United States indicates that workers with occupational exposure to turkeys, particularly abattoir workers, have significantly higher odds (approximately 3 times greater) of having antibodies against TAstV-2 compared to non-exposed individuals [1]. While clinical disease in these humans has not been confirmed, this finding strongly suggests that human infection or at least immune exposure occurs. From a prevention standpoint, this underscores the need for personal protective equipment (PPE) such as masks and eye protection in high-dust environments, as well as rigorous hygiene protocols to prevent fecal-oral transmission. It also highlights a potential route of mechanical transmission if personnel move between farms or between the farm and the slaughterhouse without proper decontamination.

Strategic Diagnostic Surveillance: The Sentinel for Control

Effective control is impossible without accurate and timely diagnosis. TAstV infections, especially in subclinical or mild forms, are easily missed without active surveillance [2, 26]. Furthermore, the frequent co-infections with other enteric viruses (rotavirus, coronavirus, reovirus, and parvovirus) complicate clinical diagnosis [4, 13, 17, 29]. Therefore, molecular diagnostics form the bedrock of any control strategy.

Molecular Detection and Differentiation: Reverse transcription polymerase chain reaction (RT-PCR) and its quantitative variant (RT-qPCR) are the primary tools for detection [8, 20, 26]. These assays target conserved regions of the genome, such as the RNA-dependent RNA polymerase (RdRp) gene in ORF1b, which is sufficiently conserved to detect diverse strains [8, 20, 21]. However, given the high genetic variability, particularly in the capsid gene, it is essential to use assays that can differentiate between TAstV-1, TAstV-2, and ANV, as their pathogenic profiles may differ [2, 17, 19]. Studies from Poland, Ecuador, and Turkey have demonstrated that a single flock can harbor multiple TAstV types simultaneously [8, 13, 19]. For comprehensive control, surveillance programs should employ multiplex RT-PCR platforms that can simultaneously screen for the major enteric viruses (TAstV, TCoV, rotavirus, reovirus, and parvovirus), as this provides a clearer understanding of the disease complex driving production losses in a given outbreak [17, 26].

Sequencing for Epidemiological Insight: Beyond mere detection, molecular characterization through sequencing is indispensable for controlling TAstV. Phylogenetic analysis of the capsid (ORF2) and polymerase (ORF1b) genes reveals the origin of strains, tracks their movement across regions, and identifies recombinant viruses [21, 24]. The discovery of recombination events between TAstV and goose astroviruses (GAstV) in China, for instance, highlights the potential for interspecies transmission and the emergence of novel, potentially more virulent strains [5, 9, 24]. Similarly, evidence of recombination among US TAstV isolates demonstrates that this is not an isolated phenomenon [21]. Routine sequencing of a subset of positive samples from different flocks or geographic regions can serve as an early warning system for the emergence of escape mutants or more pathogenic strains. This is aligned with the WOAH/FAO (Food and Agriculture Organization) concept of “One Health” surveillance for emerging pathogens.

Sample Selection and Limitations: The choice of clinical sample critically affects diagnostic sensitivity. For live birds, cloacal swabs are convenient, but studies have shown that intestinal contents (from the ileum and ceca) and sections of the bursa of Fabricius, thymus, and spleen often yield higher viral loads and higher detection rates [3, 32]. In one Brazilian study, samples from the ileum-ceca region had nearly twice the odds of being positive for TAstV and TCoV compared to feces [32]. For post-mortem surveillance, fresh intestinal contents and lymphoid tissues (bursa and spleen) should be prioritized. It is vital to note that even sensitive RT-PCR can yield false negatives if the virus is not shedding at the time of sampling or if viral RNA has been degraded by nucleases in the sample. Therefore, repeat sampling over the first 2-4 weeks of life, the peak period for TAstV detection and clinical disease [13, 17], is recommended for accurate flock profiling.

Immune-Based Control: Vaccination and Maternal Immunity

Currently, no globally licensed, widely available commercial vaccine specifically targeting TAstV-1 or TAstV-2 exists for turkeys. However, the development of effective vaccines is a high research priority, and several avenues are being explored based on a deep understanding of viral pathogenesis.

The Enterotoxin Model and Vaccine Design: A paradigm-shifting discovery is that the TAstV-2 capsid protein alone, independent of viral replication, is sufficient to induce acute diarrhea when administered orally to poults [12]. This capsid protein acts as an enterotoxin, disrupting the intestinal epithelial barrier by redistributing the sodium-hydrogen exchanger 3 (NHE3) from the cell membrane to the cytoplasm, leading to sodium malabsorption and osmotic diarrhea [12, 18]. This finding has profound implications for vaccine design. A successful vaccine must elicit robust mucosal immunity, specifically neutralizing antibodies that block the capsid protein from binding to and interacting with enterocytes. An immunoglobulin Y (IgY)-based approach, where antibodies against the recombinant capsid protein are produced in hens and passively administered to poults, could be a viable short-term strategy. However, this would be cost-prohibitive at a commercial scale.

The Promise of Live-Attenuated and Recombinant Vaccines: Experimental studies have shown that while TAstV-2 from clinically affected birds is more pathogenic, subclinical strains exist that replicate and induce seroconversion without causing severe disease [2]. This suggests that a live-attenuated vaccine, derived from a naturally apathogenic strain, is biologically plausible. Such a vaccine could be administered via drinking water or spray at the hatchery, mimicking natural infection routes. However, the risk of reversion to virulence and the potential recombination with wild-type strains, especially given the high frequency of recombination in astroviruses [21, 24], is a significant safety concern.

A more promising avenue is a vectored vaccine using a safe avian virus backbone (e.g., herpesvirus of turkeys, HVT) to express the TAstV-2 capsid protein. This would provide a DIVA (Differentiating Infected from Vaccinated Animals) capability, which is critical for epidemiological monitoring. Additionally, subunit vaccines based on the capsid spike protein, delivered with a potent mucosal adjuvant (e.g., cholera toxin B subunit), could induce strong local IgA responses. The genetic and antigenic diversity of TAstV-2, with capsid gene nucleotide identities as low as 69% among field isolates [21], presents a major hurdle. A successful vaccine may need to be multivalent, incorporating antigens from several major circulating lineages, or target the more conserved, yet immunologically relevant, domains of the capsid.

Harnessing Maternal Immunity: In the absence of active vaccination of poults, optimizing maternal immunity is the most practical immune-based strategy currently available. Breeder flocks that have been naturally infected or strategically exposed to field strains (a practice of “feedback”) develop antibodies that are passively transferred to progeny via the egg yolk. These maternal antibodies can protect poults during the critical first week of life, reducing viral shedding and the severity of clinical signs. However, the duration of this protection is finite, often waning by 7-10 days of age, leaving poults vulnerable as they enter the peak period of susceptibility [13, 17]. A controlled “feedback” program using well-characterized, non-pathogenic TAstV-2 isolates to boost breeder immunity before the laying period could be a component of an integrated control plan, provided its use is carefully monitored to avoid the introduction of virulent or recombinant strains.

Mitigating the Impact of Co-Infections

Any control strategy that ignores the polymicrobial nature of turkey enteritis is doomed to fail. TAstV is rarely, if ever, a single agent in severe disease. The literature is replete with examples of co-infections with turkey coronavirus (TCoV), rotavirus, reovirus, hemorrhagic enteritis virus (HEV), Lawsonia intracellularis, and Salmonella spp. [4, 7, 22, 26, 29]. These co-infections synergistically exacerbate disease, leading to higher mortality and growth depression than any single agent would cause [22]. Therefore, prevention must be holistic.

Control of Immunosuppressive Agents: HEV and reovirus are known to cause immunosuppression. When they co-infect with TAstV-2, the result is a more severe disease course, often seen in PEMS [4, 7, 22]. Vaccinating breeder flocks against HEV is standard practice in many regions and should be considered a non-negotiable component of a TAstV control program. Similarly, controlling reovirus through vaccination and biosecurity helps maintain a robust immune system in poults, allowing them to better handle TAstV infection.

Broad-Spectrum Enteric Health Programs: Relying solely on a vaccine for TAstV is insufficient. A comprehensive program must include strategies to control other enteric pathogens. This includes:

• Coccidiosis control: Eimeria spp. damage the intestinal epithelium, potentially providing entry points or creating a more permissive environment for TAstV replication.
• Bacterial control: Strict hygiene to reduce levels of Salmonella, Campylobacter, and Clostridium perfringens reduces the risk of secondary bacterial overgrowth and necrotic enteritis following the virus-induced disruption of the gut microbiota.
• Mycotoxin management: Contaminated feed can damage intestinal integrity and impair immunity, synergizing with TAstV to worsen diarrhea. Implementing a robust mycotoxin management program is a supportive nutritional strategy.

Environmental and Nutritional Support

Even with the best prevention, infections will occur. Control strategies must therefore include supportive measures designed to minimize the clinical impact and accelerate recovery.

Nutritional Interventions: The hallmark of TAstV-induced disease is malabsorptive, osmotic diarrhea caused by the redistribution of NHE3 and disruption of tight junctions [12, 18]. Supportive nutritional strategies should focus on:

• Electrolyte and fluid supplementation: Providing oral rehydration solutions in the water during an outbreak can help correct dehydration and electrolyte imbalances.
• Highly digestible feed: Using pre-digested proteins (e.g., plasma protein, hydrolysates) and easily absorbable carbohydrates can reduce the digestive burden on a damaged intestine.
• Gut health additives: The use of probiotics, prebiotics (e.g., mannan-oligosaccharides), and organic acids has been explored to support a healthy gut microbiome and reduce pathogen colonization. While direct efficacy against TAstV is unproven, these additives can improve overall gut health and reduce the severity of enteritis.
• Medium-chain triglycerides (MCTs): These have antiviral activity against some enveloped viruses and are less dependent on normal fat absorption, which may be impaired during astrovirus infection.

Litter Management and Environmental Control: During an outbreak, litter becomes heavily seeded with virus. Strategies to reduce litter moisture (e.g., increasing ventilation, adding litter amendments like sodium bisulfate) can help reduce virus survival and aerosolization. Keeping litter dry is a key environmental intervention that has been statistically linked to lower transmission risk [32].

A Note on Inter-Species Transmission and Broader Implications

The prevention of TAstV infections must also consider the broader avian ecosystem. The detection of astrovirus sequences highly similar to TAstV-1 in pheasants and to TAstV-2 in goose flocks suffering from gout [5, 6, 9, 24], as well as the detection of chicken astrovirus (CAstV) in commercial turkey poults in Nigeria [10], raises the alarming possibility of cross-species transmission. Furthermore, the presence of novel astroviruses in migratory birds like the ruddy turnstone, which grouped phylogenetically with poultry astroviruses, suggests that wild birds can act as reservoirs and disseminators of these viruses across continents [11]. Therefore, farm-level biosecurity must include strict measures to prevent contact with wild birds, excluding them from feed storage areas, water sources, and barns, to prevent the introduction of novel astrovirus strains from the wild reservoir. This is a critical, albeit challenging, component of a long-term global control strategy.

References

[1] Meliopoulos VA, Kayali G, Burnham AJ, Oshansky C, Thomas P, Gray G, et al.. Detection of Antibodies against Turkey Astrovirus in Humans. PLoS ONE. 2014. DOI: https://doi.org/10.1371/journal.pone.0096934

[2] Mor S, Abin M, Costa G, Durrani A, Jindal N, Goyal S, et al.. The role of type-2 turkey astrovirus in poult enteritis syndrome. Poultry Science. 2011. DOI: https://doi.org/10.3382/ps.2011-01617

[3] Silva SDd, Bonetti A, Petrocelli A, Ferrari HF, Luvizotto M, Cardoso T. Detection of Turkey astrovirus in young poults affected with poult enteritis complex in Brazil.. Journal of Veterinary Medical Science. 2008. DOI: https://doi.org/10.1292/JVMS.70.629

[4] Villarreal L, Assayag M, Brandão P, Chacón J, Bunger A, Astolfi-Ferreira C, et al.. Identification of turkey astrovirus and turkey coronavirus in an outbreak of Poult Enteritis and Mortality Syndrome. Brazilian Journal of Poultry Science. 2006. DOI: https://doi.org/10.1590/S1516-635X2006000200010

[5] Xu P, Wang X, Wang J, Liang J, Luo Y, Liu L, et al.. Isolation, identification, and pathogenicity of two novel goose astrovirus from goslings with severe gout in China.. Microbial Pathogenesis. 2024. DOI: https://doi.org/10.1016/j.micpath.2024.106829

[6] Gál J, Ziszisz Á, Hoitsy M, Bali K, Kaszab E, Tóth T, et al.. Avian astrovirus caused mortality in pheasant (Phasianus colchicus, Linnaeus, 1758) farm in Hungary.. Acta Veterinaria Hungarica. 2024. DOI: https://doi.org/10.1556/004.2024.01076

[7] Öngör H, Bulut H, Çetinkaya B, Akan M, Tonbak S, Mor S, et al.. Detection of Astrovirus, Coronavirus and Haemorrhagic Enteritis Virus in Turkeys with Poult Enteritis Mortality Syndrome in Turkey. Journal of Poultry Science. 2015. DOI: https://doi.org/10.2141/JPSA.0150021

[8] Loor-Giler A, Sanchez-Castro C, Santander-Parra S, Andrade-Ojeda D, Puga-Torres B, Mena-Pérez R, et al.. First Molecular Evidence of the Presence of Avian Astroviruses in Turkey Flocks of Ecuador Through the Standardization of RT-qPCR Assays Based on SYBR Green. Viruses. 2026. DOI: https://doi.org/10.3390/v18030308

[9] Wang H, Zhu Y, Ye W, Hua J, Chen L, Ni Z, et al.. Genomic and Epidemiological Characteristics Provide Insights into the Phylogeographic Spread of Goose Astrovirus in China.. Transboundary and Emerging Diseases. 2022. DOI: https://doi.org/10.1111/tbed.14522

[10] Adebiyi A, McIlwaine K, Oluwayelu D, Smyth V. Detection and characterization of chicken astrovirus associated with hatchery disease in commercial day-old turkeys in southwestern Nigeria. Archives of Virology. 2021. DOI: https://doi.org/10.1007/s00705-021-05034-w

[11] Souza WMd, Fumagalli M, Araujo Jd, Ometto T, Modha S, Thomazelli L, et al.. Discovery of novel astrovirus and calicivirus identified in ruddy turnstones in Brazil. Scientific Reports. 2019. DOI: https://doi.org/10.1038/s41598-019-42110-3

[12] Meliopoulos VA, Marvin SA, Freiden P, Moser L, Nighot P, Ali R, et al.. Oral Administration of Astrovirus Capsid Protein Is Sufficient To Induce Acute Diarrhea In Vivo. mBio. 2016. DOI: https://doi.org/10.1128/mBio.01494-16

[13] Domańska-Blicharz K, Bocian Ł, Lisowska A, Jacukowicz A, Pikuła A, Minta Z. Cross-sectional survey of selected enteric viruses in Polish turkey flocks between 2008 and 2011. BMC Veterinary Research. 2017. DOI: https://doi.org/10.1186/s12917-017-1013-8

[14] Benedictis PD, Schultz‐Cherry S, Burnham AJ, Cattoli G. Astrovirus infections in humans and animals – Molecular biology, genetic diversity, and interspecies transmissions. Infection, Genetics and Evolution. 2011. DOI: https://doi.org/10.1016/j.meegid.2011.07.024

[15] Mendenhall I, Yaung KN, Joyner P, Keatts L, Borthwick S, Neves ES, et al.. Detection of a novel astrovirus from a black-naped monarch (Hypothymis azurea) in Cambodia. Virology Journal. 2015. DOI: https://doi.org/10.1186/s12985-015-0413-2

[16] Jindal N, Mor S, Goyal S. Enteric viruses in turkey enteritis. VirusDisease. 2014. DOI: https://doi.org/10.1007/s13337-014-0198-8

[17] Moura-Alvarez J, Chacón J, Scanavini L, Nuñez L, Astolfi-Ferreira C, Jones RC, et al.. Enteric viruses in Brazilian turkey flocks: Single and multiple virus infection frequency according to age and clinical signs of intestinal disease. Poultry Science. 2013. DOI: https://doi.org/10.3382/ps.2012-02849

[18] Nighot P, Moeser A, Ali R, Blikslager A, Koci M. Astrovirus infection induces sodium malabsorption and redistributes sodium hydrogen exchanger expression. Virology. 2010. DOI: https://doi.org/10.1016/j.virol.2010.02.004

[19] Domańska-Blicharz K, Seroka A, Minta Z. One-year molecular survey of astrovirus infection in turkeys in Poland. Archives of Virology. 2011. DOI: https://doi.org/10.1007/s00705-011-0958-3

[20] Koci M, Seal B, Schultz‐Cherry S. Development of an RT-PCR diagnostic test for an avian astrovirus. Journal of Virological Methods. 2000. DOI: https://doi.org/10.1016/S0166-0934(00)00228-7

[21] Pantin-Jackwood M, Spackman E, Woolcock P. Phylogenetic Analysis of Turkey Astroviruses Reveals Evidence of Recombination. Virus genes. 2006. DOI: https://doi.org/10.1007/s11262-005-6875-3

[22] Lojkić I, Biđin M, Biđin Z, Mikec M. Viral Agents Associated with Poult Enteritis in Croatian Commercial Turkey Flocks. Acta Veterinaria Brno. 2010. DOI: https://doi.org/10.2754/AVB201079010091

[23] Saif Y, Saif L, Cl H, Hayhow C, Swayne D, Rn D. A small round virus associated with enteritis in turkey poults.. Avian diseases. 1990. DOI: https://doi.org/10.2307/1591277

[24] Chen Q, Xu X, Yu Z, Sui C, Zuo K, Zhi G, et al.. Characterization and Genomic Analysis of Emerging Astroviruses Causing Fatal Gout in Goslings.. Transboundary and Emerging Diseases. 2020. DOI: https://doi.org/10.1111/tbed.13410

[25] Tregaskis PL, Devaney R, Smyth V. The First Whole Genome Sequence and Characterisation of Avian Nephritis Virus Genotype 3. Viruses. 2021. DOI: https://doi.org/10.3390/v13020235

[26] Jindal N, Patnayak D, Chander Y, Ziegler A, Goyal S. Detection and molecular characterization of enteric viruses from poult enteritis syndrome in turkeys. Poultry Science. 2010. DOI: https://doi.org/10.3382/ps.2009-00424

[27] Adebiyi A, Tregaskis PL, Oluwayelu D, Smyth V. Investigation of Enteric Viruses Associated With Runting and Stunting in Day-Old Chicks and Older Broilers in Southwest Nigeria. Frontiers in Veterinary Science. 2019. DOI: https://doi.org/10.3389/fvets.2019.00239

[28] Marié J, Davoust B, Socolovschi C, Mediannikov O, Roqueplo C, Beaucournu J, et al.. Characterization of turkey inducible nitric oxide synthase and identification of its expression in the intestinal epithelium following astrovirus infection. Comparative Immunology, Microbiology & Infectious Diseases. 2011. DOI: https://doi.org/10.1016/j.cimid.2011.10.001

[29] Moura-Alvarez J, Nuñez L, Astolfi-Ferreira C, Knöbl T, Chacón J, Moreno A, et al.. Detection of enteric pathogens in Turkey flocks affected with severe enteritis, in Brazil. Tropical Animal Health and Production. 2014. DOI: https://doi.org/10.1007/s11250-014-0612-7

[30] Aktaş O, Aydın H, Timurkan M. A molecular study on the prevalence and coinfections of Rotavirus, Norovirus, Astrovirus and Adenovirus in children with gastroenteritis.. Minerva Pediatrica. 2019. DOI: https://doi.org/10.23736/S0026-4946.16.04304-X

[31] Loor-Giler A, Galdo-Novo S, Nuñez LFN. Enteric Viruses in Turkeys: A Systematic Review and Comparative Data Analysis. Viruses. 2025. DOI: https://doi.org/10.3390/v17081037

[32] Streck AF, Souza CKd, Gonçalves K, Zang L, Pinto L, Canal C. Epidemiological aspects of astrovirus and coronavirus in poults in the South Eastern Region of Brazil. Brazilian Journal of Microbiology. 2009. DOI: https://doi.org/10.1590/S1517-83822009000200008

[33] Turan T, Işıdan H. The First Detection and Phylogenetic Analysis of Bovine Astrovirus from Diarrheic Calves in Turkey. Etlik Veteriner Mikrobiyoloji Dergisi. 2018. DOI: https://doi.org/10.35864/EVMD.513442